Table 3.
Proportion of people with CKD defined by either eGFR=15–59 ml/min per 1.73 m2 or albuminuria (with normal or unmeasured eGFR) dispensed an angiotensin-converting enzyme inhibitor/angiotensin receptor blocker or a statin in the following year by diabetes status
| CKD Defined by eGFR or Albuminuria Only | CKD with Diabetes | CKD without Diabetes | P Value | ||
|---|---|---|---|---|---|
| N | Percentage (95% CI) | N | Percentage (95% CI) | ||
| CKD defined by eGFR=15–59 ml/min per 1.73 m2 | 31,923 | 64,557 | |||
| Percentage dispensed an ACEi/ARB | |||||
| Without albuminuria | 16,566 | 77.1 (76.5 to 77.8) | 41,779 | 57.8 (57.3 to 58.3) | <0.001 |
| With albuminuria | 12,139 | 82.1 (81.5 to 82.8) | 9160 | 63.2 (62.2 to 64.2) | <0.001 |
| Unmeasured albuminuria | 3218 | 69.9 (68.2 to 71.4) | 13,618 | 55.6 (54.7 to 56.4) | <0.001 |
| Overall (irrespective of albuminuria) | 31,923 | 78.3 (77.8 to 78.8) | 64,557 | 58.1 (57.7 to 58.5) | <0.001 |
| Percentage dispensed a statin | 31,923 | 64.6 (64.0 to 65.1) | 62,689a | 39.2 (38.8 to 39.6) | <0.001 |
| CKD defined by moderate or severe albuminuria only (eGFR≥60 ml/min per 1.73 m2 or unmeasured) | 23,918 | 41,107 | |||
| Percentage dispensed an ACEi/ARB | 23,918 | 76.3 (75.8 to 76.9) | 41,107 | 26.8 (26.4 to 27.3) | <0.001 |
| Percentage dispensed a statin | 23,918 | 63.1 (62.5 to 63.7) | 18,714a | 31.6 (30.9 to 32.3) | <0.001 |
95% CI, 95% confidence interval; ACEi/ARB, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker.
a
Consistent with guidelines (5), this was restricted to those over age 50 years old.